2021
-
06
-
01
點擊次數:
中科新生命聚焦在生命大健康產業鏈建設，布局產業鏈上下游的科技服務、醫藥研發、臨床檢測三大業務板塊。公司已建立5700m2的上海研發中心、5000m2的義烏產能基地和2000m2的泰州醫學檢驗中心，同步布局全國各地的銷售分中心，2021年即將完成1100 m2 cGMP小試平臺建設。 作為大健康產業鏈上游創新引擎的科技服務事業部，已建立起以蛋白質組、修飾組、代謝組、脂質組、基因組、轉錄組為核心的創新型多組學平臺，為生命科學的發展提供堅實、專業、前沿的基礎性研究。 醫藥研發的突破引領產業的未來，生物醫藥事業部建立大分子藥物臨床前藥學研究服務，貫穿生物藥研發管線的各個環節，致力于幫助客戶解決新藥研發中的疑難雜癥。 精準醫療，大健康產業重要的發展方向。臨床診斷事業部全國布局、建設獨立醫學檢驗所，實現基礎研究到臨床應用的完美轉化，為人類的生命健康保駕護航。 Shanghai Applied Protein Technology (APT), established in 2004, focuses on healthcare and precision medicine industry, and has three business units including academic service, biopharmaceutical service and clinical service. With vigorous development in the human health field, APT has built 5700m2 of R&D center in Shanghai, 5000m2 of production site in Yiwu, Zhejiang and 2000m2 of clinical service in Taizhou, Jiangsu, with sales offices across the country. As the upstream innovation engine of health industry, Academic Service BU has established an innovative multi-proteomics platform including proteomics, post-translational modification, metabolomics, lipidomics, genomics and transcriptomics, providing robust, professional and cutting-edge basic academic research service for advancing the development of life science. R&D breakthrough leads the future of pharmaceutical industry. Biopharma Service BU offers preclinical pharmacy research services for biopharmaceutical companies’ R&D and new drug application, covering the whole line of biopharmaceutical R & D. Precision medicine is an important development direction of the health industry. Clinical Service BU of APT aims at developing advanced clinical diagnostic techniques based on mass spectrometry technology, and is establishing independent medical laboratories across the country, providing services to facilitate the translation from basic researches to clinical applications, and protecting human life and health.